Financials in USD. Standardized financial statements.
A compact view of how Xenetic Biosciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.98M | $2.50M | $2.54M | $1.71M | $1.16M | $436,942 | $17,066 | $0 | $7.58M | $3.00M |
| Revenue Growth? | +19.0% | -1.6% | +48.8% | +47.1% | +165.6% | +2460.3% | 0.0% | -100.0% | +152.8% | 0.0% |
| Cost of Revenue? | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $15,827 | $156,119 | $36,449 |
| Gross Profit? | $2.98M | $2.50M | $2.54M | $1.71M | $1.16M | $436,942 | $17,066 | -$15,827 | $7.43M | $2.96M |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | 0.0% | +97.9% | +98.8% |
| Operating Expenses? | $5.81M | $6.70M | $7.06M | $8.42M | $6.91M | $14.37M | $12.90M | $7.28M | $11.00M | $50.43M |
| Operating Income? | -$2.83M | -$4.20M | -$4.52M | -$6.72M | -$5.75M | -$13.94M | -$12.89M | -$7.28M | -$3.57M | -$47.43M |
| EBITDA? | -$2.83M | -$4.05M | -$4.52M | -$6.69M | -$5.71M | -$4.67M | -$9.58M | -$7.26M | -$3.57M | -$53.44M |
| Income Before Tax | -$2.68M | -$3.96M | -$4.13M | -$6.55M | -$5.65M | -$13.81M | -$12.78M | -$7.30M | -$3.60M | -$54.21M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$2.92M | $0 | $24,131 | $26,370 | $0 |
| Net Income? | -$2.68M | -$3.96M | -$4.13M | -$6.55M | -$5.65M | -$10.89M | -$12.78M | -$7.30M | -$3.60M | -$54.21M |
| EPS? | $-1.58 | $-2.57 | $-2.71 | $-4.49 | $-5.39 | $-17.04 | $-55.92 | $-96.58 | $-49.78 | $-875.41 |
| Diluted EPS? | $-1.58 | $-2.57 | $-2.71 | $-4.49 | $-5.39 | $-17.04 | $-55.92 | $-96.57 | $-49.78 | $-875.41 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality